Evista

Evista (raloxifene) affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue. Evista is used to treat or prevent osteoporosis in postmenopausal women. Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer. Evista is not a cancer medication and will not treat breast cancer. It is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. For osteoporosis it is less preferred than bisphosphonates. It is also used to reduce the risk of breast cancer in those at high risk.

Journal home page: http://www.sciaeon.org/targeted-drug-delivery/home

View Articles: http://www.sciaeon.org/targeted-drug-delivery/current-issue

Share your manuscript: http://www.sciaeon.org/submit-paper

For more queries: drugdelivery@sciaeonopenaccess.com